Walgreens Infusion Services plans second-lien notes for buyout

By Lisa Kerner

Charlotte, N.C., Jan. 20 – Goldman Sachs Mezzanine will provide second-lien notes for Madison Dearborn Partners’ acquisition of a majority interest in Walgreens Infusion Services, which will become an independent, privately held company.

Walgreen Co., a wholly owned subsidiary of Walgreens Boots Alliance, Inc., announced the agreement on Tuesday.

The financial terms of the agreement were not disclosed.

The transaction is expected to close during the second quarter of calendar year 2015, according to a news release.

BofA Merrill Lynch will lead the first-lien financing.

Walgreen is a Deerfield, Ill.-based drugstore chain. Walgreens Infusion Services is a provider of home and alternate treatment site infusion services.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.